The cost hike of the antidepressant, first reported on April 3, sets the price of a 120-milliliter bottle at $67.
The company also raised the price of a generic version of Vicodin and haloperidol, a schizophrenia treatment, by more than 100 percent, according to the report.
While triple-digit price hikes are not illegal, they are a rebuke of a common industry practice of keeping price increases below 10 percent annually.
Read the full report here.
More articles on pharmacy:
7 drugs projected to become blockbusters by 2023
3 insulin manufacturers to testify at House panel April 10
Cigna-Express Scripts cap out-of-pocket 30-day insulin costs at $25
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.